The FDA has already approved more than a dozen antipsychotics for schizophrenia ... before accounting for insurer rebates ...
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...